Effector memory CD8 T-cells as a novel peripheral blood biomarker for activated T-cell pediatric acute liver failure.

Effector memory CD8 T-cells as a novel peripheral blood biomarker for activated T-cell pediatric acute liver failure.
复制标题

DOI:
10.1371/journal.pone.0286394
复制
发表时间:
2023
期刊:
影响因子:
3.7
通讯作者:
--
中科院分区:
综合性期刊3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

小儿急性肝衰竭(PALF)的一种独特的表型已被确定,标记为活化t细胞肝炎。这些患者先前被纳入不确定组,有系统性免疫激活的证据,肝活检标本中CD8+ t细胞密集浸润。我们的目的是评估与不明原因的活化t细胞肝炎相比,PALF患者外周血t细胞表型。在2017-2020年期间前瞻性纳入1-17岁病因不明的PALF患者。在未知组中,如果患者进行肝活检伴有密集或中度CD8染色,且可溶性白细胞介素-2受体水平升高,则将其分类为活动性t细胞肝炎,或者如果他们不符合这些标准,则将其分类为不确定型。采集全血进行流式细胞术和t细胞表型分析。4例活化t细胞肝炎患者和4例不确定PALF患者入组。与不确定的PALF患者相比,活化t细胞肝炎患者的效应记忆(TEM)表型CD8 t细胞比例显著更高(中位数66.8% (IQR 57.4-68.7) vs 19.1% (IQR 13.4-25.2), P = 0.03)。此外,与不确定的PALF患者相比,活化t细胞肝炎患者的CD8+ TEM细胞明显更有可能呈CD103阳性,CD103是组织常驻记忆t细胞的标志(中位数12.4% (IQR 9.5-14.7) vs 4.7% (IQR 4.5-5.3), P = 0.03)。我们发现活化t细胞肝炎患者可以通过外周血效应记忆CD8+ CD103+ t细胞百分比增加的独特模式来识别。这些发现将指导未来的研究,探索这些患者的t细胞表型,以及他们是否可能对定向免疫抑制疗法有反应。
A distinct phenotype of pediatric acute liver failure (PALF) has been identified, labeled activated T-cell hepatitis. These patients, previously included within the indeterminate group, have evidence of systemic immune activation and liver biopsy specimens with dense infiltration of CD8+ T-cells. We aimed to evaluate the peripheral blood T-cell phenotype in PALF patients with activated T-cell hepatitis compared to indeterminate cause. PALF patients with unknown etiology age 1–17 years were prospectively enrolled between 2017–2020. Within the unknown group, patients were classified as either activated T-cell hepatitis if they had a liver biopsy with dense or moderate CD8 staining and an elevated soluble interleukin-2 receptor level, or they were classified as indeterminate if they did not meet these criteria. Whole blood was collected for flow cytometry and T-cell phenotyping. Four patients with activated T-cell hepatitis and 4 patients with indeterminate PALF were enrolled. Activated T-cell hepatitis patients had significantly greater percentage of CD8 T-cells that were effector memory (TEM) phenotype compared to indeterminate PALF patients (median 66.8% (IQR 57.4–68.7) vs 19.1% (IQR 13.4–25.2), P = 0.03). In addition, CD8+ TEM cells in activated T-cell hepatitis patients were significantly more likely to be CD103 positive, a marker of tissue resident memory T-cells, compared to indeterminate PALF patients (median 12.4% (IQR 9.5–14.7) vs 4.7% (IQR 4.5–5.3), P = 0.03). We found patients with activated T-cell hepatitis can be identified by the unique pattern of increased percentage of peripheral blood effector memory CD8+ CD103+ T-cells. These findings will guide future studies exploring the T-cell phenotype for these patients and whether they may respond to directed immunosuppressive therapies.
DOI: 10.1055/a-1108-1553
发表时间: 2020-05-01
影响因子: 1
作者:
Boeske, Anne-Kathrin;Sander, Annette;Pfister, Eva-Doreen
通讯作者: Pfister, Eva-Doreen
DOI: 10.1002/hep.29901
发表时间: 2018-09-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Chapin, Catherine A.;Burn, Thomas;Alonso, Estella M.
通讯作者: Alonso, Estella M.
DOI: 10.1111/petr.12296
发表时间: 2014-08-01
影响因子: 1.3
作者:
McKenzie, Rebecca B.;Berquist, William E.;Cox, Kenneth L.
通讯作者: Cox, Kenneth L.
DOI: 10.1111/j.1600-6143.2004.00559.x
发表时间: 2004-10-01
影响因子: 8.8
作者:
Molina, RA;Katzir, L;Martín, MG
通讯作者: Martín, MG
DOI: 10.1097/mpg.0b013e31827a78b2
发表时间: 2013-03
影响因子: 2.9
作者:
Bucuvalas J;Filipovich L;Yazigi N;Narkewicz MR;Ng V;Belle SH;Zhang S;Squires RH
通讯作者: Squires RH